Fascioscapulohumeral Muscular Dystrophy Clinical Trials
3 recruiting trials for Fascioscapulohumeral Muscular Dystrophy. Eligibility criteria explained in plain English.
TrialFinderData lists 3 Fascioscapulohumeral Muscular Dystrophy clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by University of Missouri-Columbia (1), Seoul National University Hospital (1), Centre Hospitalier Universitaire de Liege (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Whole-body Electrical Muscle Stimulation Exercise (device, 1 trial), followed by Shoulder orthosis, ActiMyo/Syde.
Track Fascioscapulohumeral Muscular Dystrophy trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
This single-arm pilot study evaluates the effects of whole-body electrical muscle stimulation (WB-EMS) exercise on neuromuscular and physical function in adults with neuromuscular...
The Effect of a Muscle-mimicking, Fabric-type Shoulder Orthosis on Functional Movements of the Upper Limb in Patients...
The goal of this clinical trial is to investigate the effect of a muscle-mimicking, fabric-type shoulder orthosis on functional movements of the upper limb in patients with...
Assessments in Patients With Muscular Pathology and in Control Subjects : The ActiLiège Next Study
The objective of the ActiLiège Next study is to collect longitudinal data from patients and control subjects using a wearable magneto-inertial device. By collecting natural...
Explore Other Conditions
Frequently Asked Questions
There are currently 3 clinical trials for Fascioscapulohumeral Muscular Dystrophy, with 3 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Fascioscapulohumeral Muscular Dystrophy, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Fascioscapulohumeral Muscular Dystrophy, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.